13F HOLDINGS REPORT
Merck & Co., Inc.
Quarter ended Q4 2024 · Filed February 14, 2025 · Accession 0000895345-25-000055
Total Value
$258.0M
Positions
13
Other Managers
1
Confidential Omitted
No
Holdings (13)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | MODERNA INC | MRNA | 2,308,190 | $96.0M | 37.19% |
| 2 | PERSONALIS INC | PSNL | 14,044,943 | $81.2M | 31.46% |
| 3 | KYMERA THERAPEUTICS INC | KYMR | 772,165 | $31.1M | 12.04% |
| 4 | ENTRADA THERAPEUTICS INC | TRDA | 1,739,768 | $30.1M | 11.66% |
| 5 | ALECTOR INC | ALEC | 3,545,719 | $6.7M | 2.60% |
| 6 | SUTRO BIOPHARMA INC | STRO | 2,723,509 | $5.0M | 1.94% |
| 7 | ABSCI CORPORATION | ABSI | 998,163 | $2.6M | 1.01% |
| 8 | VIRIDIAN THERAPEUTICS INC | VRDN | 93,414 | $1.8M | 0.69% |
| 9 | XILIO THERAPEUTICS INC | XLO | 1,483,758 | $1.4M | 0.55% |
| 10 | LAVA THERAPEUTICS NV | N51517105 | 1,149,345 | $1.1M | 0.42% |
| 11 | CARISMA THERAPEUTICS INC | CARM | 1,473,240 | $616,993 | 0.24% |
| 12 | EVAXION BIOTECH A/S | 29970R204 | 542,279 | $458,443 | 0.18% |
| 13 | NEUPHORIA THERAPEUTICS INC | NEUP | 10,027 | $34,393 | 0.01% |